Continuum Advisory’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$205K Buy
+1,293
New +$192K 0.02% 463
2025
Q2
Sell
-1,232
Closed -$180K 1613
2025
Q1
$180K Buy
1,232
+176
+17% +$25.6K 0.02% 414
2024
Q4
$145K Sell
1,056
-606
-36% -$88.7K 0.02% 451
2024
Q3
$240K Sell
1,662
-67
-4% -$10.2K 0.03% 367
2024
Q2
$252K Sell
1,729
-575
-25% -$82.5K 0.04% 333
2024
Q1
$330K Buy
2,304
+648
+39% +$93K 0.05% 288
2023
Q4
$226K Buy
+1,656
New +$215K 0.03% 421
2023
Q1
Sell
-1,581
Closed -$215K 448
2022
Q4
$215K Buy
+1,581
New +$210K 0.04% 390

Other funds holding XLV

Continuum Advisory's XLV Position: Q2 2026 in Review

Continuum Advisory opened a new position in State Street Health Care Select Sector SPDR ETF (XLV) in Q2 2026: 1,293 shares worth $205K. The stake represents 0.02% of the portfolio and ranks #463 among its holdings. This is a return to the name: Continuum Advisory previously reported a position in XLV as recently as Q1 2025.

Continuum Advisory first reported a position in XLV in Q4 2022 and has held it in 8 quarters since. The position peaked at $330K in Q1 2024. 1,861 funds tracked by Wall St. Rank hold XLV as of Q2 2026.

  • Continuum Advisory held 1,293 shares of State Street Health Care Select Sector SPDR ETF worth $205K as of Q2 2026.
  • State Street Health Care Select Sector SPDR ETF was a new Continuum Advisory position in Q2 2026.
  • State Street Health Care Select Sector SPDR ETF made up 0.02% of Continuum Advisory's portfolio in Q2 2026, its #463 holding.
  • Continuum Advisory first reported a position in State Street Health Care Select Sector SPDR ETF in Q4 2022 and has held it in 8 quarters since.
  • Continuum Advisory's State Street Health Care Select Sector SPDR ETF position peaked at $330K in Q1 2024.
  • 1,861 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q2 2026.

Based on Continuum Advisory's 13F filing for Q2 2026, filed 6 Aug 2026.